The clearance ushers in a closely-watched launch for Gilead, which aims to show a long-acting injection can upend a market ...

A new pilot program announced by FDA Commissioner Martin Makary would award vouchers that could cut drug reviews to one or ...

With backers such as Regeneron’s venture arm, Actio Biosciences is working on medicines that counter a wide range of ...

The funds will support Phase 2 testing of a drug the company believes to be able to safety home in on AMPA receptors, an ...